Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Wei-Xin Bei"'
Autor:
Hu Liang, Yao-Fei Jiang, Guo-Ying Liu, Lin Wang, Jian-Wei Wang, Nian Lu, Wei-Xiong Xia, Liang-Ru Ke, Yan-Fang Ye, Jin-Lin Duan, Wei-Xin Bei, Shu-Hui Dong, Wang-Zhong Li, Li-Ting Liu, Chong Zhao, Changqing Xie, Yan-Qun Xiang
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-8 (2024)
Abstract The antiangiogenic agent apatinib has been shown to clinically improve responses to immune checkpoint inhibitors in several cancer types. Patients with N3 nasopharyngeal carcinoma have a high risk of distant metastasis, however, if the addit
Externí odkaz:
https://doaj.org/article/a5f7d9030d814b3ca42fbfa3ef13a7ea
Autor:
Nian Lu, Yao-Fei Jiang, Wei-Xiong Xia, Ying Huang, Chuan-Miao Xie, Cheng Xu, Yan-Fang Ye, Guo-Ying Liu, Wei-Xin Bei, Liang-Ru Ke, Wang-Zhong Li, Cheng Zhang, Xin Wang, Qin Liu, Xi Chen, Zi-Xiong Chen, Changqing Xie, Hu Liang, Yan-Qun Xiang
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102136- (2023)
Summary: Background: There are limited treatment options for patients with metastatic nasopharyngeal carcinoma (mNPC) after failure of platinum-based chemotherapy. In this trial, we assessed the efficacy and safety of sintilimab plus bevacizumab in p
Externí odkaz:
https://doaj.org/article/4ad70bdeaf304a61850080ba101bda55
Autor:
Guo-Ying Liu, Nian Lu, Wei-Xin Bei, Wang-Zhong Li, Hu Liang, Wei-Xiong Xia, Yan-Qun Xiang, He-Rui Yao
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundWe aimed to establish a prognostic model to identify suitable candidates for chemotherapy combination PD-1 inhibitor in metastatic nasopharyngeal carcinoma (NPC) patients.Patients and methodsIn this retrospective study, we included 524 pati
Externí odkaz:
https://doaj.org/article/7f9bf4e7f50042ba8469bb5eaa7d7621
Autor:
Guo-Ying Liu, Wei-Xiong Xia, Zhuo-Fei Bi, Nian Lu, Wang-Zhong Li, Wei-Xin Bei, Hu Liang, Jun-Zhi Xie, Yi-Min Liu, He-Rui Yao, Yan-Qun Xiang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPlasma Epstein–Barr virus DNA (EBV-DNA) is a sensitive and specific biomarker for nasopharyngeal carcinoma (NPC). We investigated whether longitudinal monitoring of EBV-DNA could accurately detect clinical disease progression in NPC patie
Externí odkaz:
https://doaj.org/article/9526841f163241669358b77e1d5df611
Autor:
Guo-Ying Liu, Yan-Fang Ye, Yao-Fei Jiang, Gina Jinna Chen, Wei-Xiong Xia, Yi-Sheng Huang, Tian-Sheng Gao, Yi-Min Liu, Ya-Ting Hou, Jian-Fei Li, Jia-Hao Liu, Nian Lu, Chang-Long Chen, Liang-Ru Ke, Hu Liang, Wei-Xin Bei, Wang-Zhong Li, Shu-Hui Dong, Qin Liu, Changqing Xie
Publikováno v:
BMJ: British Medical Journal; 6/22/2024, Vol. 385 Issue 8433, p1-10, 10p
Autor:
Nian Lu, Yao-Fei Jiang, Weixiong Xia, Ying Huang, Chuanmiao Xie, Cheng Xu, Yan-Fang Ye, Guo-Ying Liu, Wei-Xin Bei, Liangru Ke, Wang-Zhong Li, Cheng Zhang, Xin Wang, Qin Liu, Xi Chen, Zi-Xiong Chen, Changqing Xie, Hu Liang, Yan-Qun Xiang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45068d1f6988e404ba2d109f2771d299
https://doi.org/10.2139/ssrn.4356780
https://doi.org/10.2139/ssrn.4356780
Autor:
Guo-Ying Liu, Wang-Zhong Li, De-Shen Wang, Hu Liang, Xing Lv, Yan-Fang Ye, Chong Zhao, Liang-Ru Ke, Shu-Hui Lv, Nian Lu, Wei-Xin Bei, Zhuo-Chen Cai, Xi Chen, Chi-Xiong Liang, Xiang Guo, Wei-Xiong Xia, Yan-Qun Xiang
Publikováno v:
JAMA Oncol
IMPORTANCE: Capecitabine maintenance therapy improves survival outcomes in various cancer types, but data are limited on the efficacy and safety of capecitabine maintenance therapy in metastatic nasopharyngeal carcinoma (NPC). OBJECTIVE: To investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fda4f5e58e51e9b540b2d7f02f07445
https://europepmc.org/articles/PMC8855317/
https://europepmc.org/articles/PMC8855317/
Autor:
Nian Lu, Hu Liang, Shu-Hui Lv, Wei-Xiong Xia, Wang-Zhong Li, Guo-Ying Liu, Xin Hua, Wei-Xin Bei, Yan-Qun Xiang
Publikováno v:
Journal of Inflammation Research
Wang-Zhong Li,1,2,* Xin Hua,3,* Shu-Hui Lv,1,2,* Hu Liang,1,2 Guo-Ying Liu,1,2 Nian Lu,1,2 Wei-Xin Bei,1,2 Wei-Xiong Xia,1,2 Yan-Qun Xiang1,2 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guang
Autor:
Xue-Feng Hu, Nian Lu, Xiang Guo, Wang-Zhong Li, Yan-Qun Xiang, Guo-Ying Liu, Shu-Hui Lv, Hai-Jun Wu, Xing Lv, Wei-Xiong Xia, Hu Liang, Wei-Xin Bei
Publikováno v:
JAMA Network Open
Key Points Question Can incorporating Epstein-Barr virus DNA status into analysis of the tumor-node-metastasis framework improve cancer staging quality in nasopharyngeal carcinoma? Findings In this multicenter prognostic study of 2354 patients in Chi
Autor:
Xiang Yanqun, Chong Zhao, Yan-Fang Ye, Wei-Xin Bei, Xi Chen, Hu Liang, Wei-Xiong Xia, Wang-Zhong Li, De Shen Wang, Mengyun Qiang, Jun-Zhi Xie, Guo-Ying Liu, Xun Cao, Nian Lu, Zhuocheng Cai, Shu-Hui Lv, Xiang Guo, Liangru Ke, Chixiong Liang, Xing Lv
Publikováno v:
Journal of Clinical Oncology. 39:6044-6044
6044 Background: Capecitabine maintenance therapy improves outcomes in various tumor types, but minimal data are available on the effect of capecitabine maintenance therapy in metastatic nasopharyngeal carcinoma (NPC). We aimed to investigate whether